Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-02 Sale | 2025-06-03 4:20 pm | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 13,861 | $8.05 | $111,581 | 206,805 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:42 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,862 | $7.17 | $13,351 | 281,623 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:40 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 2,974 | $7.17 | $21,324 | 207,104 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:39 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,024 | $7.18 | $21,712 | 262,974 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 5:37 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,219 | $7.18 | $152,352 | 3,499,099 (Direct) | View |
| 2025-05-08 Purchase | 2025-05-12 8:50 pm | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 10,000 | $6.96 | $69,600 | 172,704 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 6:27 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 21,475 | $6.87 | $147,533 | 3,520,318 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 6:25 pm | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 3,061 | $6.87 | $21,029 | 265,998 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 6:24 pm | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 3,009 | $6.87 | $20,672 | 210,078 (Direct) | View |
| 2025-02-24 Sale | 2025-02-26 6:22 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,895 | $6.84 | $12,962 | 283,485 (Direct) | View |
| 2025-01-31 Sale | 2025-02-04 7:16 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 17,420 | $7.8209 | $136,239 | 193,444 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 07:52 am | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 2,948 | $9.01 | $26,561 | 269,059 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 07:51 am | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 2,897 | $9.01 | $26,102 | 213,087 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 07:49 am | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,814 | $9 | $16,326 | 174,380 (Direct) | View |
| 2024-11-25 Sale | 2024-11-27 07:47 am | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 20,680 | $9.01 | $186,327 | 791,793 (Direct) | View |
| 2024-08-23 Sale | 2024-08-27 5:19 pm | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 1,832 | $9.02 | $16,525 | 176,194 (Direct) | View |
| 2024-08-23 Sale | 2024-08-27 5:17 pm | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 20,880 | $9.02 | $188,338 | 812,473 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-06-23 9:12 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Meyers Steve Lawrence Chief Commercial Officer | 0 | $0 | 664,728 (Direct) | View |
Ownership | 2025-06-23 9:09 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Saroj Namrata Chief Business Officer | 0 | $0 | 666,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:26 pm | N/A 2035-02-11 | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 2,750,000 | $0 | 2,750,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:26 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director | 58,000 | $0 | 90,933 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:25 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director | 58,000 | $0 | 90,933 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:24 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 58,000 | $0 | 230,704 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:24 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director | 58,000 | $0 | 95,433 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:23 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director | 58,000 | $0 | 130,464 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:21 pm | N/A 2035-06-10 | OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director | 58,000 | $0 | 94,000 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:38 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks | 2,750,000 | $0 | 3,541,793 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:37 pm | N/A 2035-02-10 | OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer | 316,000 | $0 | 457,666 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:36 pm | N/A 2035-02-10 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 459,115 | $0 | 652,559 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 8:35 pm | N/A 2035-02-10 | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 445,000 | $0 | 619,380 (Direct) | View |
| 2024-10-07 Option Award | 2024-10-09 5:32 pm | N/A 2034-10-06 | OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer | 395,200 | $0 | 395,200 (Direct) | View |
| 2024-10-02 Option Award | 2024-10-04 5:21 pm | N/A 2034-10-01 | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 300,000 | $0 | 415,984 (Direct) | View |
| 2024-10-02 Option Award | 2024-10-04 5:20 pm | N/A 2034-10-01 | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 300,000 | $0 | 472,007 (Direct) | View |
Ownership | 2024-10-04 5:18 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer | 0 | $0 | 682,650 (Direct) | View |
Ownership | 2024-10-04 5:17 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer | 0 | $0 | 745,186 (Direct) | View |
| 2024-08-29 Option Award | 2024-09-03 4:08 pm | N/A 2034-08-28 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 44,636 | $0 | 242,590 (Direct) | View |
| 2024-02-27 Exercise | 2024-07-26 7:30 pm | N/A 2024-04-13 | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 30,302 | $0 | 198,704 (Direct) | View |
| 2024-02-27 Exercise | 2024-07-26 7:30 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 30,302 | $8.8 | 198,704 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 7:30 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 48,000 | $0 | 198,704 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 6:41 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director | 48,000 | $0 | 68,933 (Direct) | View |
| 2024-07-24 Option Award | 2024-07-26 6:40 pm | N/A 2034-07-23 | OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director | 48,000 | $0 | 68,933 (Direct) | View |